Everest Organics Ltd

Everest Organics Limited submitted a certificate to the BSE Limited on October 8, 2026, confirming compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as certified by Venture Capital and Corporate Investments Private Limited, the company's Registrar to an Issue and Share Transfer Agent.

Everest Organics Limited will close its trading window from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ended September 30, 2026, for directors, promoters, designated employees, persons, specified connected persons, and their immediate relatives, in accordance with SEBI’s insider trading regulations.

Everest Organics Limited announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) to the company's board, effective August 14, 2026, for a term of five consecutive years subject to member approval. The company also reconstituted its Audit, Nomination and Remuneration, Stakeholders Relationship, and Corporate Social Responsibility Committees, and approved its Board's Report for the Financial Year 2025-26, alongside the Notice for the 33rd Annual General Meeting scheduled for September 30, 2026.

Everest Organics Limited announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) to the company's board, effective August 14, 2026, for a term of five consecutive years subject to member approval. The company also reconstituted its Audit, Nomination and Remuneration, Stakeholders Relationship, and Corporate Social Responsibility Committees, and approved its Board's Report for the Financial Year 2025-26, alongside the Notice for the 33rd Annual General Meeting scheduled for September 30, 2026. Additionally, Everest Organics Limited has appointed Mr. Y. Ravi Prasada Reddy as the Scrutinizer for the upcoming Annual General Meeting.

Everest Organics Limited announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) to the company's board, effective August 14, 2026, for a term of five consecutive years subject to member approval. The company also reconstituted its Audit, Nomination and Remuneration, Stakeholders Relationship, and Corporate Social Responsibility Committees, and approved its Board's Report for the Financial Year 2025-26, alongside the Notice for the 33rd Annual General Meeting scheduled for September 30, 2026. Additionally, Everest Organics Limited has appointed Mr. Y. Ravi Prasada Reddy as the Scrutinizer for the upcoming Annual General Meeting.

Everest Organics Limited will hold a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and the Limited Review Report of the Statutory Auditors pertaining to those results, as well as to approve the Board’s Report for the fiscal year 2025-26 and fix the time, date, and venue of the 33rd Annual General Meeting. The company also noted that the trading window closure period, which began on July 1, 2026, will remain closed until 48 hours after the declaration of the unaudited financial results.

Net profit of Everest Organics declined 9.62% to Rs 2.63 crore in the quarter ended March 2026 as against Rs 2.91 crore during the previous quarter ended March 2025. Sales rose 19.11% to Rs 48.75 crore in the quarter ended March 2026 as against Rs 40.93 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 5.55 crore in the year ended March 2026 as against net loss of Rs 1.29 crore during the previous year ended March 2025. Sales rose 23.00% to Rs 196.16 crore in the year ended March 2026 as against Rs 159.48 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales48.7540.93 19 196.16159.48 23 OPM %13.748.40 -10.104.53 - PBDT4.102.51 63 14.532.72 434 PBT2.170.95 128 8.05-3.24 LP NP2.632.91 -10 5.55-1.29 LP Powered by Capital Market - Live

Everest Organics will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Everest Organics declined 68.42% to Rs 0.36 crore in the quarter ended December 2025 as against Rs 1.14 crore during the previous quarter ended December 2024. Sales rose 1.28% to Rs 42.59 crore in the quarter ended December 2025 as against Rs 42.05 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales42.5942.05 1 OPM %8.319.56 - PBDT2.562.62 -2 PBT1.041.15 -10 NP0.361.14 -68 Powered by Capital Market - Live

Everest Organics has postponed the meeting of the Board of Directors which was scheduled to be held on 11 February 2026. The meeting will now be held on 14 February 2026.Powered by Capital Market - Live